Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Clinical Diagnostics
Precision Medicine Is Having a Moment. Finally!
Precision medicine has finally reached its long-awaited inflection point, with top diagnostics companies now posting real, exponential growth that validates a decades-long bet that diagnostics would matter as much as drugs.
June 8, 2026
Blog Article
Clinical Diagnostics
Precision Medicine Is Having a Moment. Finally!
Precision medicine has finally reached its long-awaited inflection point, with top diagnostics companies now posting real, exponential growth that validates a decades-long bet that diagnostics would matter as much as drugs.
June 8, 2026
Clinical Diagnostics
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | May Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of May.
June 3, 2026
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | May Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of May.
June 3, 2026
Next-Generation Therapeutics
In The Press
Pharma & Biotech
The Consulting Report: From Lab to Leadership: Carl Schoellhammer on Strategy and Venture at DeciBio
Carl Schoellhammer, Ph.D. shares how DeciBio bridges deep technical expertise and real strategic decision-making across precision medicine, venture, and beyond.
May 26, 2026
In The Press
Pharma & Biotech
The Consulting Report: From Lab to Leadership: Carl Schoellhammer on Strategy and Venture at DeciBio
Carl Schoellhammer, Ph.D. shares how DeciBio bridges deep technical expertise and real strategic decision-making across precision medicine, venture, and beyond.
May 26, 2026
DeciBio Ventures
Blog Article
Pharma & Biotech
Chemical vs. Recombinant: The Manufacturing Decisions Behind Blockbuster Peptide Drugs
From GLP-1 blockbusters to emerging pipelines, the battle between chemical synthesis and recombinant expression is reshaping how — and by whom — the next generation of peptide drugs gets made.
May 20, 2026
Blog Article
Pharma & Biotech
Chemical vs. Recombinant: The Manufacturing Decisions Behind Blockbuster Peptide Drugs
From GLP-1 blockbusters to emerging pipelines, the battle between chemical synthesis and recombinant expression is reshaping how — and by whom — the next generation of peptide drugs gets made.
May 20, 2026
Next-Generation Therapeutics
pharma
Infographic
Clinical Diagnostics
Digital Pathology Partner Landscape Update - Q2 2026
Tracker updated as of April 1, 2026.
May 13, 2026
Infographic
Clinical Diagnostics
Digital Pathology Partner Landscape Update - Q2 2026
Tracker updated as of April 1, 2026.
May 13, 2026
Digital Pathology
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | April Round-Up 2026
Liquid Biopsy (LBx) continued to develop through April, featuring new clinical and research collaborations as well as trial launches and study results.
May 12, 2026
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | April Round-Up 2026
Liquid Biopsy (LBx) continued to develop through April, featuring new clinical and research collaborations as well as trial launches and study results.
May 12, 2026
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved